Rapid effects of statins - From prophylaxis to therapy for ischemic stroke

[1] HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 556 - 562

[2] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 391 - 397

[4] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8880 - 8885

[5] Withdrawal of statins increases event rates in patients with acute coronary syndromes [J]. CIRCULATION, 2002, 105 (12) : 1446 - 1452

[6] Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (05) : 981 - 987

[7] Statins and the risk of dementia [J]. LANCET, 2000, 356 (9242) : 1627 - 1631

[8] Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice [J]. STROKE, 2000, 31 (10) : 2442 - 2448

[9] Neuroprotection mediated by changes in the endothelial actin cytoskeleton [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) : 15 - 24

[10] *MULT RISK FACT IN, 1976, JAMA-J AM MED ASSOC, V235, P825

[1] HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 556 - 562

[2] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 391 - 397

[4] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8880 - 8885

[5] Withdrawal of statins increases event rates in patients with acute coronary syndromes [J]. CIRCULATION, 2002, 105 (12) : 1446 - 1452

[6] Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (05) : 981 - 987

[7] Statins and the risk of dementia [J]. LANCET, 2000, 356 (9242) : 1627 - 1631

[8] Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice [J]. STROKE, 2000, 31 (10) : 2442 - 2448

[9] Neuroprotection mediated by changes in the endothelial actin cytoskeleton [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) : 15 - 24

[10] *MULT RISK FACT IN, 1976, JAMA-J AM MED ASSOC, V235, P825